DH Tamarac Research Center

Tamarac, Florida 33321

5 studies enrolling now · 11 studies all time

What they study most

Atopic Dermatitis, Attention-Deficit/Hyperactivity Disorder, COPD, Chronic Migraine, Diabetic Kidney Disease (DKD), Diabetic Nephropathies, Gout, Hidradenitis Suppurativa, Minimal Change Disease, Primary Focal Segmental Glomerulosclerosis, Primary Immunoglobulin A Nephropathy, Primary Membranous Nephropathy

Studies at this site

• Study of WAL0921 in Patients With Glomerular Kidney Diseases — Recruiting now
• Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease — Recruiting now
• A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. — Recruiting now
• Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS — Recruiting now
• A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. — Recruiting now
• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD — Recruiting now
• Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — Completed
• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling
• A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus — Completed
• Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis — Completed